About IntegriChain
IntegriChain is a Healthcare company based in Philadelphia (United States) founded in 2005, and was acquired by Nordic Capital in November 2023. Inventory, order and customer relationship management solution for life science suppliers. IntegriChain has raised $2 million across 4 funding rounds from investors including Accel-KKR, SaaS Capital and Activate Venture Partners. The company has 282 employees. IntegriChain has completed 4 acquisitions, including Blue Fin Group, Federal Compliance Solutions and Medical Communication Technologies. Its website integrichain.com draws about 18 thousand monthly visits. Its Indian entity Integrichain Private Limited reported revenue of ₹81.20 Cr. IntegriChain offers products and services including ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access. Its focus areas include Biopharma Outsourcing, Consulting, Diversified and HealthTech. Its competitors include Indegene, IMS Health and Axtria; 2 of its 3 listed competitors have raised funding.
Company details
IntegriChain was founded in 2005 in Philadelphia, United States, focusing on the life sciences sector. Supply chain relationships, inventories, and orders are managed for healthcare suppliers across retailers, ecommerce platforms, and distributors. Tools including Demand Visibility for tracking product distribution, Scorecard for agreement management, Signals for order monitoring, and Order Planning for forecasting are offered. Additional services encompass training, custom reporting, data integration, and returns forecasting.
- Headquarters Philadelphia, United States
- Employees 282
- Stage Acquired
- SectorsHealthcare
- Website integrichain.com
- Social LinkedIn X Facebook
- Acquired by Nordic Capital (Nov 2023)
- Legal Name Integrichain Private Limited
- Date of Incorporation 06 Jun, 2011
- Jurisdiction Pune, Maharashtra, India
- Indian entity revenue₹81.20 Cr
FY 2025 · +27% YoY
- Indian entity net profit₹7.22 Cr
FY 2025 · 9% margin
- Indian entity EBITDA₹11.42 Cr
FY 2025 · 14% margin
- Total Equity Funding$2M (USD)
in 4 rounds
- InvestorsAccel-KKR
& 5 more
- Employee Count282
- Investments & AcquisitionsBlue Fin Group
& 3 more
- Acquired byNordic Capital
(Nov 2023)
Associated legal entities of IntegriChain
IntegriChain operates through Integrichain Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Integrichain Private Limited CIN U72200PN2011PTC139750 | Active | 06 Jun 2011 | Pune, Maharashtra | ₹81.2 Cr | 282 | 3 | View details |
Products & Services of IntegriChain
IntegriChain offers a comprehensive portfolio of products and services, including ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access.
Platform for pharmaceutical data and commercialization insights
Tools for managing pharma contracts and pricing obligations
Services for forecasting and managing gross-to-net revenue
Analytics for product utilization and channel data
Solutions for enhancing patient data and adherence
Funding Insights of IntegriChain
IntegriChain has successfully raised a total of $2M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 4
- First Round $2M
(Oct 2006)
- Investors Count 5
All 4 funding rounds of IntegriChain with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | Private Equity Round | – | – | ||
| Sep 2015 | $6M | Debt – Venture | – | – | |
| Jul 2009 | Series B | – | Activate Venture Partners | ||
| Oct 2006 | $2M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in IntegriChain
IntegriChain has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Accel-KKR, SaaS Capital and Activate Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on mid-market software and technology-enabled services firms. | accel-kkr.com | Menlo Park, United States | ||
Early-stage venture capital is provided by Activate Venture Partners. | activatevp.com | New York, United States | ||
Investments are made in early to mid-stage US companies. | xacp.com | Radnor, United States | ||
Early-stage venture capital investments are focused on US companies. | njtcvc.com | Mount Laurel Township, United States | ||
| nordiccapital.com | ||||
| saas-capital.com |
Investor details for IntegriChain
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Integrichain Private Limited (IntegriChain)
Integrichain Private Limited is the primary company behind IntegriChain. The board of Integrichain Private Limited currently have 3 directors; the longest-serving is Vikram Gajanan Patil, appointed in 2019. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikram Gajanan Patil DIN 08561608 | Director | 16 Sep 2019 | 7 yrs 1 mo | Integrichain Private Limited |
| Bradley Robert Burget DIN 08901925 | Director | 08 Oct 2020 | 6 yrs 1 mo | Integrichain Private Limited |
| Sachin Balkrishna Sadekar DIN 09028087 | Director | 18 Feb 2021 | 5 yrs 8 mo | Integrichain Private Limited |
People of IntegriChain
191 people are tracked at IntegriChain (64 in leadership, 127 in team); the tracked headcount is 282.
| Name | Role | Group |
|---|---|---|
Clay Willis | Partner | Leadership |
Sumit Pandey | Chief Scrum Master / RTE | Leadership |
Chad Garber | Executive Director, Industry Solutions | Leadership |
Mary Iken | Director, GTN Advisory Services | Leadership |
Darsani Patel | Director Of Finance And Operations | Leadership |
Matt Heyman | Chief Financial Officer | Leadership |
Shai Fiss | Chief AI & Technology | Leadership |
Kyle Zajac | Vice President Finance | Leadership |
Gregory Katz | Senior Director, Service Delivery Management | Leadership |
Krishnan Padmanabhan | Vice President, Strategic Accounts | Leadership |
Melanie Gaffney | Vice President Of Marketing | Leadership |
Francesco Polizzi | Director, Sales | Leadership |
Josh Halpern | Co-Founder & CEO | Leadership |
Brad Burget | CTO | Leadership |
| SVP & Managing Director, India Operations | Leadership | |
William Roth | SVP & Managing Partner, Consulting | Leadership |
Brenda Mulligan | Senior Director | Leadership |
Nick O'Brien | Sr. Director - GP Operations | Leadership |
Dharmesh Desai | Executive Director, Sales | Leadership |
Nishant M Shah | Director - Solution Delivery & Integration | Leadership |
171 more people are available in the full profile.
Complete people profiles for IntegriChain
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of IntegriChain
Figures of Integrichain Private Limited, the primary company behind IntegriChain, for FY 2025. Revenue was ₹81.20 Cr (+27% year on year). Net profit was ₹7.22 Cr (9% margin). EBITDA was ₹11.42 Cr (14% margin). Revenue has grown at a compounded annual rate of +1265% over three years and +49% over five years.
- ₹81.20 CrRevenue · FY 2025 · +27% YoY
- ₹7.22 CrNet profit · 9% margin
- ₹11.42 CrEBITDA · 14% margin
- ₹4.15 CrPaid-up capital
- 282Employees (provident fund records)
- +1265%Revenue CAGR, 3 years
- +49%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Integrichain Private Limited are on its company page.
Detailed financial statements for IntegriChain
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntegriChain
IntegriChain has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Blue Fin Group, Federal Compliance Solutions and Medical Communication Technologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of government pricing and contracting advisory consulting to the life sciences industry | federalcompliancesolutions.com | Philadelphia, United States | 2017 | Jul 2024 | •••• | |
Healthcare consultancy, GPO, and management services are provided. | consultbfg.com | New York, United States | 2001 | Jan 2022 | •••• | |
Distributor of electric valve accessories | medcommtech.com | Acworth, United States | 2000 | Feb 2018 | •••• | |
Investment consulting, data management, and reporting services are provided. | pharmametricsinc.com | Fort Washington, United States | 1998 | Apr 2017 | •••• |
Complete acquisition details for IntegriChain
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of IntegriChain
8 dated milestones of IntegriChain across 19 years, from founding to its latest funding, stage changes and deals.
- Founded IntegriChain is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Private Equity Round,.
- Acquisition Acquires PharmaMetrics.
- Acquisition Acquires Medical Communication Technologies.
- Acquisition Acquires Blue Fin Group.
- Exit Acquired by Nordic Capital.
- Acquisition Acquires Federal Compliance Solutions.
Competitors of IntegriChain
IntegriChain has 3 listed competitors in our database, 2 of them funded. They include Indegene, IMS Health and Axtria.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| imshealth.com | 1954 | Danbury, United States | 17,574 | SaaS and AI-based market intelligence is provided for healthcare companies. | ||
| axtria.com | 2009 | Berkeley Heights, United States | $198.74M | 749 | Data analytics and AI solutions are provided for life sciences. |
Detailed competitors of IntegriChain
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IntegriChain
The website of IntegriChain (integrichain.com) receives about 18.5K visits a month.
- Monthly visits18.5K
▲ 75% vs previous month
Websites whose visitors overlap most with IntegriChain. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kpmgcampus.com | kpmgcampus.com | 100% | – | ||
careers.epic.com | careers.epic.com | 60% | #109,290 | – | |
| glassdoor.com | 49% | 30.5M | #1,976 | View details | |
| mindworxsoftware.com | 32% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as IntegriChain (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Integrichain
Complete news archive for IntegriChain
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntegriChain
IntegriChain was founded in 2005 and raised its 1st funding round 1 year after it was founded.
IntegriChain is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
IntegriChain is a funded company, having raised a total of $2M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Oct 2006.
IntegriChain has 282 employees.
The primary company behind IntegriChain, Integrichain Private Limited, reported revenue of ₹81.20 Cr for FY 2025, up 27% year on year.
IntegriChain was founded in 2005 in Philadelphia, United States, focusing on the life sciences sector. Supply chain relationships, inventories, and orders are managed for healthcare suppliers across retailers, ecommerce platforms, and distributors. Tools including Demand Visibility for tracking product distribution, Scorecard for agreement management, Signals for order monitoring, and Order Planning for forecasting are offered. Additional services encompass training, custom reporting, data integration, and returns forecasting.
IntegriChain's top competitors include Indegene, Axtria and IMS Health.
IntegriChain offers ICyte Platform, Contracts & Pricing, Gross-to-Net, Channel Insights, and Patient Access.
IntegriChain has made 4 acquisitions, including Blue Fin Group, Federal Compliance Solutions, and Medical Communication Technologies.
IntegriChain has 6 investors. Key investors include Accel-KKR, SaaS Capital, Activate Venture Partners, Cross Atlantic Capital Partners, and NJTC Venture Fund.
IntegriChain operates through Integrichain Private Limited.
Yes. IntegriChain was acquired by Nordic Capital in November 2023.